This discussion will last for about 45 minutes, so we'll be keeping our discussion brief and quick moving. ![]() ![]() Before we continue, I have a few housekeeping items to take care of. And across much of the world, frontline health workers who do need to be vaccinated are not getting vaccines. They have secured the vast majority of the supply, whereas we're seeing health systems near collapse, so much death and human suffering in places like Brazil and in India. So right now, a lot of the world's richest countries have accumulated many of the vaccines. But my family is still in Ethiopia and they don't have really prospects of getting vaccinated before 2023 or 2024. Our audience members today are probably in the United States, where again, many people have been vaccinated. In the UK where 38 or so percent of the population already has had at least a first shot of the COVID-19 vaccine. What do we mean by equitable access? Some of us may have personal stories about this, for example, I'm based in London. And to get to the main topic of our webinar today, we're going to be talking about the current and future to COVID-19 vaccines. Some of you may know Doctors Without Borders, by French-named Médecins Sans Frontière, or MSF, and throughout this webinar we'll be using MSF. I'm Selam Gebrekidan, and I'm an investigative reporter within New York Times, and I'm based in London. Welcome, and thank you for joining us for this episode of the webinar in our spring series called Let's Talk Vaccines. Information will be posted on our upcoming events page soon. If you have any questions or comments about our webinar series, please email Stay tuned for information about our next online discussions. Our spring webinar series, Let's Talk Vaccines, has now concluded. These are some of the most effective public health interventions available. Whether we’re vaccinating against common diseases like measles or pneumonia, or fighting newer threats like Ebola and COVID-19, we know that vaccines work. MSF has nearly 50 years of experience delivering lifesaving vaccines in extreme conditions. MSF experts will draw on their experience to answer your questions about this urgent topic. We’ll also look ahead to future opportunities for the development of vaccines that better meet the needs of our patients. ![]() We’ll discuss how our medical teams respond to epidemics, provide routine vaccinations amid crisis and conflict, and speak out for equitable access to vaccines. At a time of intense global focus on COVID-19 vaccines, join Doctors Without Borders/Médecins Sans Frontières (MSF) this spring for a three-part webinar series exploring our work on immunization.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |